Cost-Effectiveness Analysis of a Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder

por Velez, Fulton F., Malone, Daniel C.
Publicado 2021

Exhalation delivery system with fluticasone improves quality of life and health status: pooled analysis of phase 3 trials NAVIGATE I and II

por Soler, Zachary M., Colman, Sam, Velez, Fulton F., Schlosser, Rodney J.
Publicado 2020

Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder

por Velez, Fulton F, Colman, Sam, Kauffman, Laura, Ruetsch, Charles, Anastassopoulos, Kathryn, Maricich, Yuri A
Publicado 2021

Real-World Reductions in Healthcare Resource Utilization over 6 Months in Patients with Substance Use Disorders Treated with a Prescription Digital Therapeutic

por Shah, Neel, Velez, Fulton F., Colman, Samuel, Kauffman, Laura, Ruetsch, Charles, Anastassopoulos, Kathryn, Maricich, Yuri
Publicado 2022

Reduced Healthcare Resource Utilization in Patients with Opioid Use Disorder in the 12 Months After Initiation of a Prescription Digital Therapeutic

por Velez, Fulton F., Anastassopoulos, Kathryn P., Colman, Samuel, Shah, Neel, Kauffman, Laura, Murphy, Sean M., Ruetsch, Charles, Maricich, Yuri A.
Publicado 2022

Real-World Evaluation of Clinical Response and Long-Term Healthcare Resource Utilization Patterns Following Treatment with a Digital Therapeutic for Chronic Insomnia

por Forma, Felicia, Knight, Tyler G, Thorndike, Frances P, Xiong, Xiaorui, Baik, Rebecca, Velez, Fulton F, Maricich, Yuri A, Malone, Daniel C
Publicado 2022